Find Expert Doctors on Anaplastic Thyroid Carcinoma481 top medical experts on Anaplastic Thyroid Carcinoma across 37 countries and 28 U.S. states, including 408 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.
- Anaplastic Thyroid Carcinoma: An aggressive thyroid gland malignancy which generally occurs in iodine-deficient areas in people with previous thyroid pathology such as goiter. It is associated with cell dedifferentiation of thyroid carcinoma (e.g., follicular thyroid carcinoma; papillary thyroid cancer). Typical initial presentation is a rapidly growing neck mass which upon metastasis is associated with dysphagia; neck pain; bone pain; dyspnea; and neurologic deficits.
- Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
- Broader Categories (#Experts): Carcinoma (3,648).
- Clinical Trials
: at least 48 including 3 Active, 14 Completed, 15 Recruiting
- Perrier, Nancy D Surgical Oncology
Professor of Surgery and Chief, Section of Surgical Endocrinology; Associate Director, Multidisciplinary Endocrine Center; and Fellowship Program Director of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.PhysicianMedical school: Louisiana State University School of Medicine In New Orleans (MD, 1993)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 68/100Subjects: Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Neoplasm StagingCategories: Pathology; Methods - Tuttle, Robert Michael Endocrinology, Diabetes & Metabolism Division of Subspecialty Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Top HospitalDisclosed payments from biomedical company (Taiho Oncology, Inc.) in 2021 for $109.25Subjects: Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Papillary; ImmunophenotypingCategories: Pathology; Genetics; Diagnosis; Immunology; Methods; Secondary
- Cabanillas, Maria E Endocrinology, Diabetes & Metabolism Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.Disclosed payments in 2021 from 9 biomedical companies, totalling $18,580, including $12,255 from Exelixis Inc.Subjects: Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Mutation; Carcinoma, NeuroendocrineCategories: Therapeutic Use; Drug Therapy; Genetics; Therapy; Pathology; Diagnosis
- Bible, Keith C Medical Oncology Mayo Clinic, Rochester, MN. Top HospitalSubjects: Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Antineoplastic Agents; Phenylurea Compounds; Quinolines; Antibodies, Monoclonal, HumanizedCategories: Drug Therapy; Therapeutic Use; Therapy; Metabolism; Diagnosis; Standards
- Wirth, Lori J Medical Oncology Harvard Medical School, Massachusetts General Hospital, Boston, MA. Top HospitalMedical school: Columbia University College of Physicians and Surgeons (MD, 1997)Medicare AcceptedDisclosed payments in 2021 from 14 biomedical companies, totalling $28,430, including $7,590 from Exelixis Inc.Subjects: Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Carcinoma, Neuroendocrine; Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Antineoplastic AgentsCategories: Drug Therapy; Genetics; Therapy; Therapeutic Use; Pharmacology; Antagonists & Inhibitors
- Fagin, James A Internal Medicine Division of Subspecialty Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Top HospitalMedical school: Other (MD, 1973)Medicare AcceptedSubjects: Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Proto-Oncogene Proteins B-raf; Adenocarcinoma, Follicular; Carcinoma, Papillary; ImmunophenotypingCategories: Genetics; Pathology; Metabolism; Diagnosis; Drug Therapy; Immunology
- Haugen, Bryan R Endocrinology, Diabetes & Metabolism Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Colorado Anschutz Medical Campus, Aurora, Colorado.Medical school: Mayo Medical School (MD, 1987)Medicare AcceptedSubjects: Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Adenocarcinoma, Follicular; Biomarkers, Tumor; Genetic Variation; Lymphocytes, Tumor-InfiltratingCategories: Genetics; Pathology; Immunology; Radiotherapy; Diagnosis
- Williams, Michelle D Anatomic Pathology & Clinical Pathology Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.Medical school: University of Florida College of Medicine (MD, 2000)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 68/100Disclosed payments in 2021 from 3 biomedical companies, totalling $8,335.75, including $8,335.75 from Bayer HealthCare Pharmaceuticals Inc.Subjects: Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell-Free Nucleic Acids; Neoadjuvant TherapyCategories: Therapeutic Use; Drug Therapy; Genetics; Pathology; Therapy; Diagnostic Imaging
- Ganly, Ian Otolaryngology Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Top HospitalSubjects: Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Thyroid Cancer, Papillary; Thyroidectomy; Carcinoma, PapillaryCategories: Genetics; Pathology; Therapy; Diagnosis; Therapeutic Use; Methods
- Shaha, Ashok R Surgery Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Top HospitalSubjects: Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Thyroidectomy; Airway Management; Medical OncologyCategories: Therapy; Methods; Therapeutic Use; Standards
- Zafereo, Mark E Otolaryngology Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.Subjects: Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Neoadjuvant Therapy; ThyroidectomyCategories: Therapeutic Use; Drug Therapy; Genetics; Therapy; Pathology; Diagnostic Imaging
- Ferrarotto, Renata Medical Oncology Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.Disclosed payments in 2021 from 3 biomedical companies, totalling $8,270, including $3,500 from Merck Sharp & Dohme CorporationSubjects: Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Agents; Neoadjuvant Therapy; ThyroidectomyCategories: Therapeutic Use; Drug Therapy; Genetics; Therapy; Epidemiology; Adverse Effects
- Kebebew, Electron Surgery Stanford University, School of Medicine, Stanford, California, USA. Top HospitalSubjects: Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Antineoplastic Agents; MicroRNAs; Cell Movement; Cell ProliferationCategories: Drug Therapy; Genetics; Pharmacology; Therapy; Antagonists & Inhibitors; Chemistry
- Gunn, Gary Brandon Radiation Oncology Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.Subjects: Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Neoadjuvant Therapy; ThyroidectomyCategories: Therapy; Therapeutic Use; Genetics; Drug Therapy; Epidemiology; Pathology
- Bowles, Daniel W Medical Oncology Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.Physician Highly CitedDisclosed payments in 2021 from 3 biomedical companies, totalling $2,310, including $2,310 from Exelixis Inc.Subjects: Thyroid Carcinoma, Anaplastic; Biomarkers, Tumor; Antineoplastic Agents, Immunological; Genetic Variation; Protein Kinase Inhibitors; Thyroid NeoplasmsCategories: Drug Therapy; Therapeutic Use; Antagonists & Inhibitors; Diagnosis; Etiology; Genetics
- Busaidy, Naifa Lamki Endocrinology, Diabetes & Metabolism Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.Medical school: Baylor College of Medicine (MD, 1997)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 68/100Disclosed payments in 2021 from 2 biomedical companies, totalling $3,500, including $1,850 from Eisai Inc.Subjects: Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cell-Free Nucleic AcidsCategories: Therapeutic Use; Genetics; Drug Therapy; Therapy; Diagnosis; Pathology
- Pozdeyev, Nikita Internal Medicine Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, Aurora, CO, USA; Division of Biomedical Informatics and Personalized Medicine, Department of Medicine, Aurora, CO, USA.Subjects: Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Adenocarcinoma, Follicular; Biomarkers, Tumor; Genetic Variation; Oncogene Proteins, FusionCategories: Genetics; Pathology; Radiotherapy; Diagnosis; Etiology; Therapy
- Foote, Robert L Radiation Oncology Department of Radiation Oncology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA. Top HospitalSubjects: Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; B7-H1 Antigen; ChemoradiotherapyCategories: Therapy; Metabolism; Diagnosis; Drug Therapy; Therapeutic Use; Standards
- Lai, Stephen Y Pediatric Cardiology Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.Subjects: Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Antineoplastic Agents; Biomarkers, Tumor; Neoadjuvant Therapy; ThyroidectomyCategories: Metabolism; Therapy; Therapeutic Use; Pathology; Drug Therapy; Epidemiology
- Smallridge, Robert C Endocrinology, Diabetes & Metabolism Mayo Clinic, Jacksonville, Florida, USA. Top HospitalSubjects: Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Apoptosis; Calgranulin A; Cell Division; Cell ProliferationCategories: Genetics; Metabolism; Therapy; Antagonists & Inhibitors; Diagnosis; Drug Effects
These expert listings are
for individual use without a fee. Biotechs,
Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and
other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards,
and consulting. Please contact
us for licensing, customized queries, feedback and questions.
Note:
- These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
- Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.